Revenue: US$33.3m (up 48% from 3Q 2023). Net loss: US$45.0m (loss widened by 1.8% from 3Q 2023). US$0.73 loss per share.

Enticed by a reward of $1 million, a former police officer helped a foreign scam syndicate use Singapore as a conduit to ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the issuance of a new patent for istaroxime in Hong Kong, titled ...

Investigations revealed that a French pharmaceutical company fell victim to a business e-mail impersonation scam by the syndicate in March 2020. The firm transferred more than $10 million for what ...

Easton Parish Council is on "the brink of bankruptcy" but cannot meet to discuss its woes... because its clerk has been sacked.

Ultragenyx Pharmaceutical RARE during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how ...

Q3 2024 Earnings Call Transcript November 4, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.38, expectations were $4.14. Operator: Good day. And welcome to ...

Reports Q3 revenue $175.7M, consensus $157.3M. The company said, “For the third quarter and first nine months of 2024, strong performance ...

英为财情Investing.com - Supernus Pharmaceuticals (NASDAQ: SUPN)星期一发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.69，总营收为$175.69M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$157.3M，每股收益为 ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price ...

The drugmaker posted revenue of $117.1 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $114.8 million. BioCryst expects full-year revenue in the range of ...